Recombinant Mouse CD93 protein (rFc Tag) (HPLC verified)
种属
Mouse
纯度
>90 %, SDS-PAGE
>90%, SEC-HPLC
标签
rFc Tag
生物活性
未测试
验证数据展示
产品信息
| 纯度 | >90 %, SDS-PAGE >90%, SEC-HPLC |
| 内毒素 | <0.1 EU/μg protein, LAL method |
| 生物活性 |
Not tested |
| 来源 | HEK293-derived Mouse CD93 protein Ala23-Asn572 (Accession# O89103) with a rabbit IgG Fc tag at the C-terminus. |
| 基因ID | 17064 |
| 蛋白编号 | O89103 |
| 预测分子量 | 85.1 kDa |
| SDS-PAGE | 110-120 kDa, reducing (R) conditions |
| 组分 | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
| 复溶 | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
| 储存条件 |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
| 运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
背景信息
CD93 (also known as complement protein 1 q subcomponent receptor C1qR1 or C1qRp) is a transmembrane glycoprotein consisting of 652 amino acids. CD93 can exist in two forms: soluble (sCD93) and membrane-bound (CD93). CD93 is expressed predominantly on endothelial cells, where it plays a key role in the promotion of angiogenesis in physiology and disease. CD93 is also highly expressed in tumor-associated blood vessels, and its presence is associated with poor prognosis, poor response to immunotherapy, immune cell infiltration, and high tumor, lymph node, and metastasis (TNM) stages in many cancer types. (PMID: 37443812) Targeting CD93-related signaling pathways in the tumor microenvironment may be a novel therapeutic strategy for tumor immunotherapy.
参考文献:
1. Tossetta G, et al. Cells. 2023;12(13):1778. 2. Sun Y, et al. Sci Transl Med. 2021;13(604):eabc8922. 3. Guo A, et al. Front Immunol. 2022;13:907182. 4. Wu B,et al. Front Immunol. 2023;14:984816.

